EQRx Announces New Data on Lead Oncology Programs to Be Presented at 2022 ASCO Annual Meeting
EQRx, Inc. (EQRX)
Company Research
Source: GlobeNewswire
First presentation of data from a pre-specified interim overall survival analysis of the Phase 3 GEMSTONE-302 study of sugemalimab in patients with previously untreated Stage IV non-small cell lung cancer (NSCLC)Oral presentation featuring the primary analysis from Phase 2 GEMSTONE-201 study of sugemalimab in patients with relapsed or refractory extranodal NK/T-cell lymphoma (ENKTL), a rare and aggressive form of Non-Hodgkin lymphomaInitial presentation on the activity of aumolertinib in patients with central nervous system (CNS) metastases from Phase 3 AENEAS study in advanced EGFR-mutated NSCLC CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today announced that new data on its lead oncology programs will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from June 3 t
Show less
Read more
Impact Snapshot
Event Time:
EQRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EQRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EQRX alerts
High impacting EQRx, Inc. news events
Weekly update
A roundup of the hottest topics